✦ LIBER ✦

Negative impact of leakage on survival of patients undergoing curative resection for advanced gastric cancer

✍ Scribed by Han Mo Yoo; Han Hong Lee; Jung Ho Shim; Hae Myung Jeon; Cho Hyun Park; Kyo Young Song

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 174 KB
Volume: 104
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.22045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of anastomotic leakage on long-te

Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer

✍ C. S. McArdle; D. C. McMillan; D. J. Hole 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

The impact of blood loss, obstruction an

The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer

✍ C. S. McArdle; D. C. McMillan; D. J. Hole 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Adjuvant chemotherapy enhances long-term

Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection

✍ Yoshihiko Maehara; Sunao Moriguchi; Yoshihisa Sakaguchi; Yasunori Emi; Shunji Ko 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Norwegian multicentre study of survival

Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma

✍ Dr. T. K. Haugstvedt; A. Viste; G. E. Eide; O. Söreide 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 2 views

Impact of ductal resection margin status

Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma

✍ Toshifumi Wakai; Yoshio Shirai; Tetsuya Moroda; Naoyuki Yokoyama; Katsuyoshi Hat 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

Impacts of fluorouracil-metabolizing enz

Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer

✍ Wasaburo Koizumi; Satoshi Tanabe; Mizutomo Azuma; Kenji Ishido; Ken Nishimura; T 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB

## Abstract A phase III trial of S‐1 plus cisplatin (SP) __versus__ S‐1 alone, for first‐line treatment of advanced gastric cancer (SPIRITS trial), has shown that overall survival was better in patients treated with SP than with S‐1 alone. In the present retrospective biomarker study, we aimed to d